DreamCIS INC. Logo

DreamCIS INC.

Contract research organization for pharma, biotech, and medical device industries.

223250 | KO

Overview

Corporate Details

ISIN(s):
KR7223250002
LEI:
Country:
South Korea
Address:
서울특별시 종로구 사직로 130 적선현대빌딩, 10층 10호, 서울특별시

Description

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-09-12 00:00
주주총회소집공고
Korean HTML 99.0 KB
2025-08-14 00:00
주주총회소집결의 (임시주주총회)
Korean HTML 8.8 KB
2025-08-14 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.5 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean HTML 1.5 MB
2025-06-11 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean HTML 1.5 MB
2025-05-09 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 15.1 KB
2025-04-30 00:00
소속부변경
Korean HTML 3.6 KB
2025-03-31 00:00
정기주주총회결과
Korean HTML 32.0 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 11.8 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean HTML 2.0 MB
2025-03-20 00:00
감사보고서제출
Korean HTML 25.7 KB
2025-03-20 00:00
[기재정정]주주총회소집공고
Korean HTML 445.3 KB
2025-03-13 00:00
주주총회소집결의
Korean HTML 18.5 KB
2025-03-13 00:00
주주총회소집공고
Korean HTML 215.3 KB

Automate Your Workflow. Get a real-time feed of all DreamCIS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DreamCIS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DreamCIS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.